Clairity Raises $43M for AI Breast Cancer Risk Prediction

Clairity, an AI health company, secures $43M to expand its breast cancer risk prediction platform, the first of its kind authorized by the FDA. The funding, led by ACE Global Equity and Santé Ventures, will accelerate the platforms availability and support development of new platforms for heart disease prediction.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.